Author: Fiona Craig
-
Hims & Hers Health stock rises after announcing $250 million buyback program
Hims & Hers Health, Inc. (NYSE:HIMS) saw its shares edge 1.5% higher on Monday after unveiling a fresh $250 million stock repurchase authorization, expanding its capital return strategy following the completion of its prior $100 million buyback plan launched in July 2024. The new three-year authorization gives the digital health platform flexibility to repurchase Class…
-
Plug Power shares slip after Susquehanna cuts price target despite UK contract win
Plug Power Inc. (NASDAQ:PLUG) came under pressure in Monday’s premarket session, dropping 5.1% after Susquehanna analyst Biju Perincheril lowered the firm’s price target to $2.50 from $3.50, while reiterating a Neutral stance. The revised forecast arrives even as Plug Power recently disclosed a major step forward in the UK, where it has been tapped to…
-
Ford partners with Amazon to bring certified pre-owned vehicles to online shoppers
Ford Motor Co. (NYSE:F) is rolling out a new digital retail initiative that will allow consumers to purchase certified pre-owned Ford vehicles directly through Amazon’s (NASDAQ:AMZN) online marketplace, expanding the automaker’s push into e-commerce. The program—launching first in Los Angeles, Seattle, and Dallas—will feature inventory from roughly 20 participating Ford dealerships, with more stores preparing…
-
Soluna shares surge 8% on strong revenue growth and improved margins
Soluna Holdings, Inc. (NASDAQ:SLNH) rallied on Monday after the company reported third-quarter financial results that showed solid operational momentum, marked by strong sequential revenue growth and a sharp improvement in gross margins—even as overall net losses widened due to non-cash accounting adjustments. Shares jumped 8.38% in pre-market trading following the announcement. The green data-center infrastructure…
-
Aptera Motors shares rise 5% after posting narrower Q3 loss
Aptera Motors Corp. (NASDAQ:SEV), the solar-electric vehicle developer pursuing ultra-efficient mobility, reported a smaller adjusted loss for the third quarter of 2025, easing investor concerns as the company moves closer to validation and eventual production. Shares climbed 5.45% in pre-market trading following the update. The company recorded an adjusted net loss of -$0.12 per share…
-
OS Therapies shares slip 5% after deeper Q3 loss tied to regulatory push
OS Therapies Inc. (AMEX:OSTX) reported a larger third-quarter loss on Monday as the biotech moves into a heavier phase of regulatory preparation for its osteosarcoma therapy OST-HER2. The company posted a net loss of $0.21 per share for the period, widening from the $0.18 loss recorded a year earlier. Shares fell 5.56% in pre-market trading…
-
Dell seen gaining from robust AI demand as new orders outweigh margin pressures
Dell Technologies (NYSE:DELL) is expected to post an improved earnings outlook, supported by strong momentum in AI-related server demand, with JPMorgan arguing that accelerating order volumes should more than compensate for a less favorable margin profile. Ahead of Dell’s fiscal third-quarter report, JPMorgan placed the stock on its Positive Catalyst Watch, pointing to healthy near-term…
-
Pedevco stock rises nearly 3% despite earnings and revenue miss in third quarter
Pedevco Corp. (AMEX:PED) reported weaker-than-expected third-quarter financial results on Monday, yet its shares still advanced as investors focused on the company’s recent operational activity and upcoming integration of newly acquired assets. The stock climbed 2.77% in pre-market trading, even as the energy producer posted breakeven earnings per share—falling short of the $0.01 profit analysts anticipated.…
-
Tonix Pharmaceuticals stock rises as TONMYA becomes available for fibromyalgia
Tonix Pharmaceuticals (NASDAQ:TNXP) saw its shares climb 8% on Monday after the company announced that TONMYA, its newly approved treatment for fibromyalgia, has officially launched in the U.S. and is now available by prescription. TONMYA (cyclobenzaprine HCl sublingual tablets) is a once-nightly, non-opioid pain therapy intended for adults diagnosed with fibromyalgia. The FDA granted approval…
-
Freightos shares rise over 2% as revenue jumps 24% on digital freight booking growth
Freightos Limited (NASDAQ:CRGO) saw its stock climb more than 2% in pre-market trading on Monday after the company posted strong third-quarter results, highlighted by another surge in digital freight bookings. The global freight-tech firm reported Q3 revenue of $7.7 million, up 24% year over year, as shippers and carriers increasingly adopt online booking platforms. Shares…